Nephrotoxicity versus anti-tumour efficacy in radiopeptide therapy: facts and myths about the Scylla and Charybdis

Eur J Nucl Med Mol Imaging. 2002 Feb;29(2):277-9. doi: 10.1007/s00259-001-0713-1.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Animals
  • Humans
  • Kidney / injuries
  • Kidney / radiation effects*
  • Neoplasms / radiotherapy*
  • Octreotide / adverse effects
  • Octreotide / analogs & derivatives*
  • Octreotide / therapeutic use
  • Peptides / adverse effects*
  • Peptides / therapeutic use*
  • Radiopharmaceuticals / adverse effects*
  • Radiopharmaceuticals / therapeutic use*
  • Radiotherapy Dosage
  • Yttrium Radioisotopes / adverse effects
  • Yttrium Radioisotopes / therapeutic use

Substances

  • Peptides
  • Radiopharmaceuticals
  • Yttrium Radioisotopes
  • Octreotide
  • Edotreotide